David Jollow to Biotransformation
This is a "connection" page, showing publications David Jollow has written about Biotransformation.
Connection Strength
0.197
-
Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther. 2001 May; 297(2):509-15.
Score: 0.050
-
Biochemical basis for dose response relationships in reactive metabolite toxicity. Adv Exp Med Biol. 1981; 136 Pt A:99-113.
Score: 0.049
-
Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat. Biochem Pharmacol. 1989 Jan 15; 38(2):289-97.
Score: 0.021
-
Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther. 1988 Jan; 244(1):118-25.
Score: 0.020
-
Use of the NIH shift to determine the relative contribution of competing pathways of aniline metabolism in the rat. Drug Metab Dispos. 1986 Nov-Dec; 14(6):689-91.
Score: 0.018
-
Hydroxylamines and hemolytic anemia. Adv Exp Med Biol. 1986; 197:573-82.
Score: 0.017
-
Glutathione thresholds in reactive metabolite toxicity. Arch Toxicol Suppl. 1980; 3:95-110.
Score: 0.011
-
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology. 1974; 11(3):151-69.
Score: 0.007
-
Formation of chemically reactive metabolites of phenacetin and acetaminophen. Adv Exp Med Biol. 1981; 136 Pt B:931-50.
Score: 0.003